Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

The Male-Factor Share of Infertility

Why Roughly Half of Cases Involve a Male Factor - and Why the Man Is Still Under-Evaluated

Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Epidemiological/health-systems topic (no FDA product); reflected in WHO, ASRM, and AUA male-infertility guidance

Reference only. Not medical advice.

What can go wrong

Under-evaluating the male partner delays diagnosis, exposes the female partner to unnecessary or premature interventions (including IVF that masks rather than treats a male cause), and misses the chance to detect serious underlying conditions - male infertility has been associated with higher rates of testicular cancer, certain other malignancies, and cardiometabolic and overall mortality risk in cohort studies. The semen analysis is also a window into general male health that is frequently left unopened.

This is something to take to a clinician. The Atlas can tell you what is known about the male-factor share of infertility in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Across infertile couples, a male factor contributes in roughly half of cases - solely in around a fifth to a third and as a contributing factor in another large share. Despite this, evaluation, treatment, and cultural blame skew heavily toward the female partner, and many men are never adequately worked up. The semen analysis is cheap and fast, yet it is frequently delayed or skipped, and infertility can be the first sign of broader male health problems.

A male factor is involved about half the time - yet the workup, and the blame, default to the woman.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Framing infertility as a couple's issue requiring parallel male evaluation
  • Justifying early semen analysis rather than female-first workups
  • Recognizing male infertility as a marker of broader health risk

How it works

Conception requires viable gametes from both partners; a deficiency in sperm number, motility, morphology, or DNA integrity can cause or contribute to infertility just as ovulatory, tubal, or uterine factors can. Because the semen analysis is simple and the male contribution is roughly equal to the female, guideline bodies recommend concurrent evaluation of both partners - yet systemic, cultural, and access factors push the workup toward the woman and delay the man's.

What people get wrong

  • Often saidInfertility is mostly a female issue

    ActuallyA male factor is involved in roughly half of cases. The asymmetry in evaluation and blame is cultural and structural, not biological.

  • Often saidIf IVF is planned, the man does not really need a workup

    ActuallySkipping the male workup can miss a treatable cause and serious underlying disease, and commits couples to ART that may be avoidable.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

What we do not know

  • How can health systems close the gap so male and female partners are evaluated in parallel?
  • Should semen quality be leveraged as a routine male-health screen, not just a fertility test?
  • What share of 'unexplained' couple infertility is undiagnosed male factor?

At a glance

Male factor involved
~50 percent of infertile couples (sole or contributing)
Male factor sole cause
commonly cited ~20-30 percent of couples
First-line male test
Semen analysis - inexpensive and noninvasive
Care gap
Men frequently under-evaluated or evaluated late

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about The Male-Factor Share of Infertility. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • WHO and epidemiological estimates of male factorMultiple sources

    A male factor is implicated in roughly half of infertile couples and is the sole cause in a substantial minority

  • Male infertility and mortality/cancer associations2009-2010s (e.g., Walsh et al.; Jensen et al.; Eisenberg et al.)

    Severely subfertile/infertile men showed higher subsequent risks of testicular cancer and increased all-cause mortality, framing semen quality as a general-health biomarker

  • AUA/ASRM male-infertility best-practice guidance2010s-2020s

    Recommends evaluation of the male partner in parallel with the female, including history, exam, and at least one semen analysis